Hou X - Search Results

1

Targeting histone deacetylases for cancer therapy: Trends and challenges.

Liang T, Wang F, Elhassan RM, Cheng Y, Tang X, Chen W, Fang H, Hou X. Liang T, et al. Among authors: hou x. Acta Pharm Sin B. 2023 Jun;13(6):2425-2463. doi: 10.1016/j.apsb.2023.02.007. Epub 2023 Feb 18. Acta Pharm Sin B. 2023. PMID: 37425042 Free PMC article. Review.

2

3D-QSAR study on a series of Bcl-2 protein inhibitors using comparative molecular field analysis.

Hou X, Du J, Fang H, Li M. Hou X, et al. Protein Pept Lett. 2011 May;18(5):440-9. doi: 10.2174/092986611794927992. Protein Pept Lett. 2011. PMID: 21171944

3

Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.

Guan P, Sun F, Hou X, Wang F, Yi F, Xu W, Fang H. Guan P, et al. Among authors: hou x. Bioorg Med Chem. 2012 Jun 15;20(12):3865-72. doi: 10.1016/j.bmc.2012.04.032. Epub 2012 Apr 21. Bioorg Med Chem. 2012. PMID: 22579621

4

A facile method for the synthesis of N-(α-aminoacyl) sulfonamides.

Wu SL, Chen ML, Wang YT, Hou XB, Yang XY, Su L, Fang H. Wu SL, et al. Among authors: hou xb. Drug Discov Ther. 2012 Apr;6(2):62-8. Drug Discov Ther. 2012. PMID: 22622015 Free article.

5

Density functional theory based quantitative structure-property relationship studies on coumarin-based prodrugs.

Yang X, Hou X, Wang B, Li M, Fang H. Yang X, et al. Among authors: hou x. Biosci Trends. 2012 Oct;6(5):234-40. doi: 10.5582/bst.2012.v6.5.234. Biosci Trends. 2012. PMID: 23229116 Free article.

6

How to improve docking accuracy of AutoDock4.2: a case study using different electrostatic potentials.

Hou X, Du J, Zhang J, Du L, Fang H, Li M. Hou X, et al. J Chem Inf Model. 2013 Jan 28;53(1):188-200. doi: 10.1021/ci300417y. Epub 2013 Jan 2. J Chem Inf Model. 2013. PMID: 23244516

7

Cadmium is a potent inhibitor of PPM phosphatases and targets the M1 binding site.

Pan C, Liu HD, Gong Z, Yu X, Hou XB, Xie DD, Zhu XB, Li HW, Tang JY, Xu YF, Yu JQ, Zhang LY, Fang H, Xiao KH, Chen YG, Wang JY, Pang Q, Chen W, Sun JP. Pan C, et al. Among authors: hou xb. Sci Rep. 2013;3:2333. doi: 10.1038/srep02333. Sci Rep. 2013. PMID: 23903585 Free PMC article.

8

Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitors.

Han L, Wang L, Hou X, Fu H, Song W, Tang W, Fang H. Han L, et al. Among authors: hou x. Bioorg Med Chem. 2014 Mar 1;22(5):1529-38. doi: 10.1016/j.bmc.2014.01.045. Epub 2014 Feb 1. Bioorg Med Chem. 2014. PMID: 24525003

9

High-performance liquid chromatographic enantioseparation of 3,5-disubstituted hydantoins analogs and temperature-induced reversals of elution orders on a polysaccharide-based chiral stationary phase.

Yang X, Su L, Hou X, Ding S, Xu W, Wang B, Fang H. Yang X, et al. Among authors: hou x. J Chromatogr A. 2014 Aug 15;1355:291-5. doi: 10.1016/j.chroma.2014.06.022. Epub 2014 Jun 12. J Chromatogr A. 2014. PMID: 24973033

10

Antagonists of IAP proteins: novel anti-tumor agents.

Wan Y, Liu T, Hou X, Dun Y, Guan P, Fang H. Wan Y, et al. Among authors: hou x. Curr Med Chem. 2014;21(34):3877-92. doi: 10.2174/0929867321666140826115258. Curr Med Chem. 2014. PMID: 25174926 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,146 results

Search Page